Skip to main content
. 2014 Dec;20(12):2006–2014. doi: 10.3201/eid2012.140548

Table 1. First passage VPSPr inoculations to Tg(HuPrP) harboring the same PrP 129 genotype as the inoculum*.

Inoculum Tg(HuPrP) No. with clinical signs/total Histology, immunohistochemistry
PrPSc Western blot
No. positive/total Dpi 
positive/total† No. positive/total Dpi 
positive/total
VPSPr-129VV 1st‡ (129V)×8§
0/11 3/9 741 ± 76/741 ± 55 4/11 768 ± 74/733 ± 71
VPSPr-129VV 2nd 0/17 10/12 711 ± 65/722 ± 59 6/17 635 ± 204/682 ± 131
VPSPr-129VV 3rd
0/11
3/8
669 ± 92/651 ± 89

3/10
642 ± 157/604 ± 140
VPSPr-129VV 4th (129V)×3
0/9 7/9 655 ± 67/642 ± 104 NA NA
VPSPr-129VV 5th
0/6
3/6
541 ± 96/642 ± 76

NA
NA
VPSPr-129MM 1st (129M)×2 0/6 4/6 678 ± 90/590 ± 154 NA NA
VPSPr-129MM 2nd
(presymptomatic) 0/6 0/6 0/746 ± 59 NA NA

Dpi, days postinoculation; M, methionine; V, valine; NA, not available; VPSPr, variably protease-sensitive prionopathy associated with homozygous V or M at codon 129 of the PrP gene (VPSPr-129VV or VPSPr-129MM).
†Dpi of positive mice compared with dpi of all mice (including positive mice). Each value represents the mean ± SD.
‡Identifies the VPSPr case-patients providing the inoculum, i.e., inocula were obtained from 5 case-patients with VPSPr-129VV and 2 with VPSPr-129MM.
§Refers to the presence of V or M at PrP residue 129 and expression level indicated as × normal.